nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—peripheral nervous system neoplasm—ocular cancer	0.733	1	CtDrD
Topotecan—ABCG2—Dactinomycin—ocular cancer	0.129	0.492	CbGbCtD
Topotecan—ABCG2—Carboplatin—ocular cancer	0.087	0.331	CbGbCtD
Topotecan—ABCB1—Dactinomycin—ocular cancer	0.0467	0.177	CbGbCtD
Topotecan—Extravasation—Carboplatin—ocular cancer	0.000486	0.13	CcSEcCtD
Topotecan—Myelosuppression—Dactinomycin—ocular cancer	0.000336	0.0899	CcSEcCtD
Topotecan—Febrile neutropenia—Dactinomycin—ocular cancer	0.000262	0.0701	CcSEcCtD
Topotecan—Extravasation—Dactinomycin—ocular cancer	0.00018	0.0483	CcSEcCtD
Topotecan—Infection—Carboplatin—ocular cancer	0.00015	0.0403	CcSEcCtD
Topotecan—Sepsis—Dactinomycin—ocular cancer	0.000137	0.0366	CcSEcCtD
Topotecan—Pain—Carboplatin—ocular cancer	0.000129	0.0347	CcSEcCtD
Topotecan—Body temperature increased—Carboplatin—ocular cancer	0.00012	0.032	CcSEcCtD
Topotecan—Lethargy—Dactinomycin—ocular cancer	0.000117	0.0312	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	0.000103	0.0276	CcSEcCtD
Topotecan—Pancytopenia—Dactinomycin—ocular cancer	9.38e-05	0.0251	CcSEcCtD
Topotecan—Neutropenia—Dactinomycin—ocular cancer	9.24e-05	0.0247	CcSEcCtD
Topotecan—Pneumonia—Dactinomycin—ocular cancer	8.86e-05	0.0237	CcSEcCtD
Topotecan—Stomatitis—Dactinomycin—ocular cancer	8.58e-05	0.023	CcSEcCtD
Topotecan—Pharyngitis—Dactinomycin—ocular cancer	7.85e-05	0.021	CcSEcCtD
Topotecan—Chills—Dactinomycin—ocular cancer	7.09e-05	0.019	CcSEcCtD
Topotecan—Alopecia—Dactinomycin—ocular cancer	6.99e-05	0.0187	CcSEcCtD
Topotecan—Ill-defined disorder—Dactinomycin—ocular cancer	6.39e-05	0.0171	CcSEcCtD
Topotecan—Anaemia—Dactinomycin—ocular cancer	6.36e-05	0.017	CcSEcCtD
Topotecan—Malaise—Dactinomycin—ocular cancer	6.21e-05	0.0166	CcSEcCtD
Topotecan—Leukopenia—Dactinomycin—ocular cancer	6.16e-05	0.0165	CcSEcCtD
Topotecan—Myalgia—Dactinomycin—ocular cancer	5.86e-05	0.0157	CcSEcCtD
Topotecan—Discomfort—Dactinomycin—ocular cancer	5.79e-05	0.0155	CcSEcCtD
Topotecan—Infection—Dactinomycin—ocular cancer	5.58e-05	0.0149	CcSEcCtD
Topotecan—Thrombocytopenia—Dactinomycin—ocular cancer	5.5e-05	0.0147	CcSEcCtD
Topotecan—Anorexia—Dactinomycin—ocular cancer	5.35e-05	0.0143	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Dactinomycin—ocular cancer	5.12e-05	0.0137	CcSEcCtD
Topotecan—Decreased appetite—Dactinomycin—ocular cancer	4.88e-05	0.0131	CcSEcCtD
Topotecan—Fatigue—Dactinomycin—ocular cancer	4.84e-05	0.013	CcSEcCtD
Topotecan—Pain—Dactinomycin—ocular cancer	4.8e-05	0.0129	CcSEcCtD
Topotecan—Feeling abnormal—Dactinomycin—ocular cancer	4.63e-05	0.0124	CcSEcCtD
Topotecan—Gastrointestinal pain—Dactinomycin—ocular cancer	4.59e-05	0.0123	CcSEcCtD
Topotecan—Body temperature increased—Dactinomycin—ocular cancer	4.44e-05	0.0119	CcSEcCtD
Topotecan—Abdominal pain—Dactinomycin—ocular cancer	4.44e-05	0.0119	CcSEcCtD
Topotecan—Hypersensitivity—Dactinomycin—ocular cancer	4.14e-05	0.0111	CcSEcCtD
Topotecan—Asthenia—Dactinomycin—ocular cancer	4.03e-05	0.0108	CcSEcCtD
Topotecan—Diarrhoea—Dactinomycin—ocular cancer	3.84e-05	0.0103	CcSEcCtD
Topotecan—Vomiting—Dactinomycin—ocular cancer	3.57e-05	0.00957	CcSEcCtD
Topotecan—Rash—Dactinomycin—ocular cancer	3.54e-05	0.00949	CcSEcCtD
Topotecan—Nausea—Dactinomycin—ocular cancer	3.34e-05	0.00894	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—CRTC1—ocular cancer	1.38e-05	0.091	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—ID2—ocular cancer	1.23e-05	0.0811	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	1.17e-05	0.0773	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	1.15e-05	0.0758	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—GNA11—ocular cancer	6.15e-06	0.0406	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—GNAQ—ocular cancer	5.71e-06	0.0378	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—ID2—ocular cancer	5.69e-06	0.0376	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—HDAC1—ocular cancer	5.15e-06	0.0341	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	4.81e-06	0.0318	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	4.73e-06	0.0313	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	4.41e-06	0.0292	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	3.81e-06	0.0252	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	3.6e-06	0.0238	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	3.52e-06	0.0233	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—CDK4—ocular cancer	3.45e-06	0.0228	CbGpPWpGaD
Topotecan—TOP1—Caspase Cascade in Apoptosis—AKT1—ocular cancer	3.4e-06	0.0225	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—ID2—ocular cancer	3.07e-06	0.0203	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	2.67e-06	0.0176	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	2.56e-06	0.0169	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	2.44e-06	0.0161	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	2.32e-06	0.0154	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	2.25e-06	0.0149	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	2.14e-06	0.0141	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—EP300—ocular cancer	2.05e-06	0.0136	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	1.91e-06	0.0126	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	1.86e-06	0.0123	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	1.86e-06	0.0123	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—EP300—ocular cancer	1.62e-06	0.0107	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	1.53e-06	0.0101	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—TP53—ocular cancer	1.47e-06	0.00972	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	1.38e-06	0.0091	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	1.29e-06	0.00855	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	1.2e-06	0.00795	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—TP53—ocular cancer	1.19e-06	0.00785	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	1.18e-06	0.0078	CbGpPWpGaD
Topotecan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	1.05e-06	0.00696	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—EP300—ocular cancer	9.52e-07	0.0063	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	7.44e-07	0.00492	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PSPH—ocular cancer	7.2e-07	0.00476	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	5.75e-07	0.00381	CbGpPWpGaD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	5.69e-07	0.00377	CbGpPWpGaD
Topotecan—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	5.28e-07	0.00349	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	5.15e-07	0.0034	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	4.95e-07	0.00327	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	4.54e-07	0.003	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	3.92e-07	0.00259	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PSPH—ocular cancer	3.89e-07	0.00257	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TGFB1—ocular cancer	3.88e-07	0.00256	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	3.7e-07	0.00245	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	3.11e-07	0.00206	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	2.74e-07	0.00181	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	2.51e-07	0.00166	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PSPH—ocular cancer	2.4e-07	0.00159	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	2.39e-07	0.00158	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	2.31e-07	0.00153	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GNA11—ocular cancer	2.27e-07	0.0015	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	2.2e-07	0.00146	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GNAQ—ocular cancer	2.11e-07	0.00139	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	1.92e-07	0.00127	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	1.91e-07	0.00126	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	1.57e-07	0.00104	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	1.33e-07	0.000879	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GNA11—ocular cancer	1.22e-07	0.00081	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GNAQ—ocular cancer	1.14e-07	0.000753	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—EP300—ocular cancer	7.57e-08	0.000501	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GNA11—ocular cancer	7.55e-08	0.000499	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GNAQ—ocular cancer	7.01e-08	0.000464	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKT1—ocular cancer	4.57e-08	0.000302	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—EP300—ocular cancer	4.09e-08	0.000271	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—EP300—ocular cancer	2.52e-08	0.000167	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKT1—ocular cancer	2.47e-08	0.000164	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKT1—ocular cancer	1.52e-08	0.000101	CbGpPWpGaD
